The Duration of Antibiotics Prophylaxis at the Time of Catheter Removal after Radical Prostatectomy: Clinically Integrated, Cluster, Randomized Trial
- PMID: 33904798
- PMCID: PMC8441991
- DOI: 10.1097/JU.0000000000001845
The Duration of Antibiotics Prophylaxis at the Time of Catheter Removal after Radical Prostatectomy: Clinically Integrated, Cluster, Randomized Trial
Abstract
Purpose: Prophylactic antibiotics are routinely given at the time of catheter removal post-radical prostatectomy (RP). The low rate of infectious complications entails that large sample sizes are required for randomized controlled trials, a challenge given the cost of standard randomized controlled trials. We evaluated infectious complications associated with 1 vs 3 days of prophylactic antibiotics at the time of catheter removal post-RP using a novel, clinically integrated trial with randomization at the surgeon level.
Materials and methods: Surgeons were cluster randomized for periods of 3 months to prescribe 1-day vs 3-day regimen of prophylactic antibiotics at the time of catheter removal. The primary end point was an infectious complication as routinely captured by nursing phone call within 10 days of catheter removal and defined as positive urine cultures (≥105 CFU) and at least 1 of the following symptoms: fever (>38°C), urgency, frequency, dysuria or suprapubic tenderness.
Results: A total of 824 patients were consented and underwent RP with, respectively, 389 and 435 allocated to 1-day and 3-day antibiotics, predominantly ciprofloxacin. Accrual was achieved within 3 years: 95% vs 88% of patients received the allocated 3-day vs 1-day antibiotic regimen. There were 0 urinary tract infections (0%) in the 1-day regimen and 3 urinary tract infections (0.7%) in the 3-day regimen, meeting our prespecified criterion for declaring the 1-day regimen to be noninferior.
Conclusions: A clinically integrated trial using cluster randomization accrued rapidly with no important logistical problems and negligible burden on surgeons. If surgeons choose to prescribe empiric prophylactic antibiotics after catheter removal following RP, then the duration should not exceed 1 day.
Keywords: clinical trial; infections; prostatic neoplasms.
Conflict of interest statement
Conflicts of interest
Andrew Vickers is named on a patent for a statistical method to detect prostate cancer that has been commercialized by OPKO Health. Andrew Vickers receives royalties from sales of the test and has stock options in OPKO Health. Behfar Ehdaie is a consultant for Consultant Myriad Genetics, and has received an honorarium from Koelis for an educational webinar.
Comment in
-
Editorial Comment.J Urol. 2021 Sep;206(3):668. doi: 10.1097/JU.0000000000001845.01. Epub 2021 Jun 2. J Urol. 2021. PMID: 34074115 No abstract available.
References
-
- Sedor J and Mulholland SG, Hospital-acquired urinary tract infections associated with the indwelling catheter. Urol Clin North Am, 1999. 26(4): p. 821–8. - PubMed
-
- Warren JW, Catheter-associated urinary tract infections. Int J Antimicrob Agents, 2001. 17(4): p. 299–303. - PubMed
-
- Banks JA, et al., Bacteriuria and antibiotic resistance in catheter urine specimens following radical prostatectomy. Urol Oncol, 2013. 31(7): p. 1049–53. - PubMed
-
- Wolf JS Jr., et al., Best practice policy statement on urologic surgery antimicrobial prophylaxis. J Urol, 2008. 179(4): p. 1379–90. - PubMed
-
- Wazait HD, et al., Antibiotics on urethral catheter withdrawal: a hit and miss affair. J Hosp Infect, 2004. 58(4): p. 297–302. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
